Posts tagged annual meeting
Ortho RTi presents 4 studies at ORS meeting

Ortho Regenerative Technologies presented results of four key scientific studies at the 2017 Orthopaedic Research Society annual meeting in San Diego, validating its product's ability to improve the repair of three distinct joint tissues: rotator cuff tendons, the meniscus and articular cartilage.

Read More
BTIG downgrades T2 Biosystems to sell

BTIG Research downgraded T2 Biosystems (NASDAQ:TTOO) to “sell” from “buy” and slashed its price target to $4 from $12. The stock closed at $7.61 on Thursday.

Read More
Titan Pharma sensitivity analyses confirm efficacy of Probuphine

Titan Pharmaceuticals (NASDAQ: TTNP) is presenting data today from four post hoc sensitivity analyses of the final Phase 3 trial of Probuphine at a poster session during The College on Problems of Drug Dependence 78th Annual Meeting in Palm Springs.

Probuphine is a six-month subdermal buprenorphine implant for the long-term maintenance treatment of opioid dependence.

Read More
Canaccord upgrades Endologix to buy

Canaccord Genuity has upgraded Endologix (NASDAQ:ELGX) to “buy” from “hold” and raised its price target to $15.50 from $11.25. The stock closed at $12.68 on Friday.

The company is developing Nellix as an endovascular aneurysm sealing (EVAS) system designed for the treatment of infrarenal abdominal aortic aneurysm (AAA) and is the only technology whose operating principle is centered on sealing the aneurysm sac.

Read More
Soricimed to present four posters at AACR

Closely-held Soricimed Biopharma and collaborators plan to present four posters at the American Association of Cancer Research (AACR) annual meeting in New Orleans on April 16-20.

The presentations are based on preclinical and clinical research conducted on the company’s lead anti-cancer drug candidate, SOR-C13, a first-in-class inhibitor of the TRPV6 calcium channel.

Read More